Cited by 8Liver Disease Diagnosis and TreatmentLiver physiology and pathologyLiver Diseases and Immunity

Ten Thousand Points of Light: Heterogeneity Among the Stars of NASH Fibrosis

Open access
Carter, James, Wang, Shuang, Friedman, Scott L.·2021·Hepatology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31807

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Single-cell studies have revealed heterogeneity within cell types in health and disease, identifying multiple HSC clusters in murine MASH fibrosis and human cirrhosis.

    “Single-cell studies have also revealed remarkable heterogeneity within different cell types in health and disease, identifying multiple HSC clusters in murine models of MASH fibrosis and human cirrhosis.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carter, J., Wang, S., & Friedman, S. L.
Affiliations
Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Friedman, Scott L.
Venue
Hepatology
Published
2021-06-11
Volume
74
Issue
2
Pages
543-546
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W3136166033
Cited by
8
References
10
Citations by year
2024: 1 · 2023: 5 · 2022: 1 · 2021: 1
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Gastroenterological Association (AGA2020‐13‐03)
  • National Institutes of Health
  • National Institute of General Medical Sciences (T32GM062754, T32GM007280)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK56621, R01DK056621, R01DK128289)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
nonalcoholic steatohepatitis, liver fibrosis, heterogeneity, liver fibrosis staging, noninvasive fibrosis assessment
MeSH terms
Fibrosis, Humans, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review